KIN - Kindred Biosciences Inc
Previous close
9.25
0 0%
Share volume: 178,496
Last Updated: Fri 27 Aug 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$9.25
0.00
0.00%
Summary score
31%
Profitability
0%
Dept financing
7%
Liquidity
66%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.31%
Return on assets
-9.7%
Return on sales
-1703.99%
Return on invested capital
-70.67%
Total debt ratio
11.83%
Debt ratio change over timeo
-1.13%
Current Ratio
14.73%
Quick Ratio
8.42%
Cash Position Ratio
6.48%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.27%
Return on assets
-6.36%
Return on sales
-1474.15%
Return on invested capital
-41.1%
Total debt ratio
27.97%
Debt ratio change over timeo
-1.39%
Current Ratio
8.31%
Quick Ratio
8.07%
Cash Position Ratio
2.67%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
27.7%
Return on assets
23.03%
Return on sales
67.48%
Return on invested capital
66.39%
Total debt ratio
25.12%
Debt ratio change over time
-1.27%
Current Ratio
10.47%
Quick Ratio
10.42%
Cash Position Ratio
3.87%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-90.3%
Return on assets
-92.67%
Return on sales
1702.6%
Return on invested capital
-40.43%
Total debt ratio
-113.15%
Debt ratio change over time
-1.13%
Current Ratio
-8.63%
Quick Ratio
-9.81%
Cash Position Ratio
-4.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KIN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -11.31% | 0% | 0% | 29.06% |
| Return on assets | -9.7% | 0% | 0% | -9.75% |
| Return on sales | -1703.99% | 0% | 0% | -1469.44% |
| Return on invested capital | -70.67% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 11.83% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.13% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 8.31% | 0% | 0% | 5.9% |
| Quick Ratio | 8.07% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.67% | 0% | 0% | 5.68% |
| Liquididy | 75% | 0% | 0% | 36% |
| Short-term ratios | KIN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -11.27% | 0% | 0% | -16.12% |
| Return on assets | -6.36% | 0% | 0% | -14.95% |
| Return on sales | -1474.15% | 0% | 0% | -3498.94% |
| Return on invested capital | -41.1% | 0% | 0% | 96.56% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 27.97% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.39% | 0% | 0% | 0.09% |
| Dept financing | 9% | 0% | 0% | 50% |
| Current Ratio | 8.31% | 0% | 0% | 5.9% |
| Quick Ratio | 8.07% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.67% | 0% | 0% | 5.68% |
| Liquididy | 62% | 0% | 0% | 61% |